Pictet Asset Management (UK)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $263M | Buy |
471,560
+38,800
| +9% | +$21.7M | 0.29% | 103 |
|
|
2021
Q1 | $205M | Sell |
432,760
-31,315
| -7% | -$14.8M | 0.25% | 118 |
|
|
2020
Q4 | $224M | Buy |
464,075
+67,874
| +17% | +$32.8M | 0.29% | 107 |
|
|
2020
Q3 | $222M | Sell |
396,201
-15,380
| -4% | -$8.61M | 0.35% | 84 |
|
|
2020
Q2 | $257M | Buy |
411,581
+24,367
| +6% | +$15.2M | 0.44% | 54 |
|
|
2020
Q1 | $189M | Sell |
387,214
-154,735
| -29% | -$75.6M | 0.4% | 65 |
|
|
2019
Q4 | $203M | Sell |
541,949
-59,335
| -10% | -$22.3M | 0.36% | 79 |
|
|
2019
Q3 | $167M | Buy |
601,284
+62,926
| +12% | +$17.5M | 0.35% | 80 |
|
|
2019
Q2 | $169M | Buy |
538,358
+45,494
| +9% | +$14.2M | 0.36% | 78 |
|
|
2019
Q1 | $202M | Buy |
492,864
+63,080
| +15% | +$25.9M | 0.45% | 53 |
|
|
2018
Q4 | $161K | Buy |
429,784
+8,906
| +2% | +$3.33K | 0.4% | 70 |
|
|
2018
Q3 | $170M | Sell |
420,878
-24,215
| -5% | -$9.78M | 0.36% | 80 |
|
|
2018
Q2 | $154M | Buy |
445,093
+5,093
| +1% | +$1.76M | 0.37% | 74 |
|
|
2018
Q1 | $152M | Buy |
440,000
+37,482
| +9% | +$12.9M | 0.37% | 74 |
|
|
2017
Q4 | $151M | Buy |
402,518
+74,619
| +23% | +$28.1M | 0.39% | 69 |
|
|
2017
Q3 | $147M | Sell |
327,899
-3,348
| -1% | -$1.5M | 0.42% | 67 |
|
|
2017
Q2 | $152M | Buy |
331,247
+928
| +0.3% | +$426K | 0.47% | 53 |
|
|
2017
Q1 | $128M | Buy |
330,319
+17,986
| +6% | +$6.97M | 0.42% | 63 |
|
|
2016
Q4 | $115M | Buy |
312,333
+34,511
| +12% | +$12.7M | 0.43% | 57 |
|
|
2016
Q3 | $112M | Sell |
277,822
-6,471
| -2% | -$2.6M | 0.42% | 59 |
|
|
2016
Q2 | $113M | Buy |
284,293
+182,092
| +178% | +$72.6M | 0.44% | 62 |
|
|
2016
Q1 | $39.2M | Sell |
102,201
-6,393
| -6% | -$2.46M | 0.17% | 152 |
|
|
2015
Q4 | $59M | Buy |
108,594
+5,630
| +5% | +$3.06M | 0.25% | 114 |
|
|
2015
Q3 | $47.9M | Buy |
102,964
+10,302
| +11% | +$4.79M | 0.21% | 133 |
|
|
2015
Q2 | $51.3M | Buy |
92,662
+31,343
| +51% | +$17.4M | 0.21% | 122 |
|
|
2015
Q1 | $28.1M | Sell |
61,319
-22,900
| -27% | -$10.5M | 0.12% | 238 |
|
|
2014
Q4 | $34.6M | Buy |
84,219
+25,819
| +44% | +$10.6M | 0.15% | 170 |
|
|
2014
Q3 | $21.1M | Sell |
58,400
-1,000
| -2% | -$361K | 0.1% | 235 |
|
|
2014
Q2 | $16.8M | Sell |
59,400
-2,100
| -3% | -$593K | 0.08% | 287 |
|
|
2014
Q1 | $18.5M | Sell |
61,500
-300
| -0.5% | -$90.1K | 0.09% | 246 |
|
|
2013
Q4 | $17M | Buy |
61,800
+8,100
| +15% | +$2.23M | 0.09% | 252 |
|
|
2013
Q3 | $16.8M | Buy |
53,700
+200
| +0.4% | +$62.6K | 0.09% | 240 |
|
|
2013
Q2 | $12M | Buy |
+53,500
| New | +$12M | 0.07% | 276 |
|